Membrane type (MT)1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat

被引:26
作者
Achong, R
Nishimura, I
Ramachandran, H
Howell, TH
Fiorellini, JP
Karimbux, NY
机构
[1] Harvard Univ, Sch Dent Med, Dept Periodontol, Boston, MA 02115 USA
[2] Louisiana State Univ, Sch Dent, Dept Oral & Maxillofacial Surg, New Orleans, LA 70119 USA
[3] Univ Calif Los Angeles, Sch Dent, Weintraub Ctr, Los Angeles, CA 90024 USA
关键词
extracellular matrix; metalloproteinases; matrix; transmembrane; models; animal; periodontitis; wound healing;
D O I
10.1902/jop.2003.74.4.494
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Matrix metalloproteinases (MMPs) have been shown to be involved in the degradation of the extracellular matrix (ECM). In particular, MMP-2 and MMP-9 (gelatinase A and gelatinase B, respectively) have been identified as the predominant MMPs during periodontitis. Recent studies have indicated that a novel transmembrane MMP, mebrane-type 1 matrix metalloproteinase (MT1-MMP), can activate pro-MMP-2 in tumor metastasis. This study aims to elucidate the presence and localization of MT1-MMP and MMP-2 in periodontitis in a rat model. Methods: In 2 groups of 40-day-old male Sprague-Dawley rats, periodontitis was initiated by ligating floss around maxillary second molars. A group of control animals were left untreated. Maxillary dentoalveolar segments were isolated after 7 and 21 days postinduction and were prepared for gross and radiographic analysis of bone loss and for histological analysis. Samples were also prepared for gel zymography to detect the presence of MMP-2, and for Northern blot analysis and in situ hybridization with MT1-MMP probes. Results: MMP-2 expression increased at 21 days following ligature placement, in conjunction with MT1-MMP expression. MT1-MMP mRNA expression was observed in epithelial cells, fibroblasts, and in multinucleated cells in the periodontium. Conclusion: Our data suggest that MT1-MMP may play a role in extracellular matrix degradation during periodontitis, in concert with MMP-2 and other proteinases.
引用
收藏
页码:494 / 500
页数:7
相关论文
共 50 条
[31]   Angiogenesis in Vestibular Schwannomas: Expression of Extracellular Matrix Factors MMP-2, MMP-9, and TIMP-1 [J].
Moller, Martin Nue ;
Werther, Kim ;
Nalla, Amarnadh ;
Stangerup, Sven-Eric ;
Thomsen, Jens ;
Bog-Hansen, Thorkild C. ;
Nielsen, Hans Jorgen ;
Caye-Thomasen, Per .
LARYNGOSCOPE, 2010, 120 (04) :657-662
[32]   Comparative Assessment of Matrix Metalloproteinase MMP-2 and MMP-9, and Their Inhibitors, Tissue Inhibitors Of Metalloproteinase TIMP-1 And TIMP-2 in Preeclampsia and Gestational Hypertension [J].
Cavalli, Ricardo ;
Palei, Ana Carol ;
Sandrim, Valeria ;
Guerlach, Raquel ;
Duarte, Geraldo ;
Tanus Santos, Jose Eduardo .
HYPERTENSION IN PREGNANCY, 2008, 27 (04) :648-648
[33]   The in vivo Expression of the collagenolytic matrix metalloproteinases (MMP-2,-8,-13, and-14) and matrilysin (MMP-7) in Adult and localized juvenile periodontitis [J].
Tervahartiala, T ;
Pirilä, E ;
Ceponis, A ;
Maisi, P ;
Salo, T ;
Tuter, G ;
Kallio, P ;
Törnwall, J ;
Srinivas, R ;
Konttinen, YT ;
Sorsa, T .
JOURNAL OF DENTAL RESEARCH, 2000, 79 (12) :1969-1977
[34]   A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth [J].
Suojanen, Juho ;
Salo, Tuula ;
Koivunen, Erkki ;
Sorsa, Timo ;
Pirila, Emma .
CANCER BIOLOGY & THERAPY, 2009, 8 (24) :2362-2370
[35]   Levels of matrix metalloproteinase-1 (MMP-1), MMP-2, MMP-3, osteopontin, pentraxin-3, and thymic stromal lymphopoietin in crevicular fluid samples from peri-implantitis, periodontitis, and healthy sites [J].
Jansson, Leif ;
Lundmark, Anna ;
Modin, Carolina ;
Gustafsson, Anders ;
Yucel-Lindberg, Tuelay .
JOURNAL OF PERIODONTAL RESEARCH, 2024,
[36]   Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue [J].
Brehmer, B ;
Biesterfeld, S ;
Jakse, G .
PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (03) :217-222
[37]   Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue [J].
B Brehmer ;
S Biesterfeld ;
G Jakse .
Prostate Cancer and Prostatic Diseases, 2003, 6 :217-222
[38]   Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25) [J].
English, WR ;
Velasco, G ;
Stracke, JO ;
Knäuper, V ;
Murphy, G .
FEBS LETTERS, 2001, 491 (1-2) :137-142
[39]   Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma [J].
Adley, Brian P. ;
Gleason, Kara J. ;
Yang, Ximing J. ;
Stack, M. Sharon .
GYNECOLOGIC ONCOLOGY, 2009, 112 (02) :319-324
[40]   MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer [J].
Sohail, Anjum ;
Sun, Qing ;
Zhao, Huiren ;
Bernardo, M. Margarida ;
Cho, Jin-Ah ;
Fridman, Rafael .
CANCER AND METASTASIS REVIEWS, 2008, 27 (02) :289-302